ANVISA Guidelines on Participant Involvement in Clinical Trials [Regulatives / Guidelines]

posted by Rajul9  – India, 2024-11-24 19:19 (80 d 14:26 ago) – Posting: # 24296
Views: 1,179

Hi all,

I’m looking for clarification on ANVISA’s regulations regarding participant eligibility for clinical trials, particularly:

Are there restrictions, such as a required gap (e.g., 180 days) after participation in another trial or blood donation?
Where can I find this information in ANVISA’s guidelines?
What’s the best way to contact ANVISA for further clarification?
Any specific references or insights would be greatly appreciated!

Thanks!

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
42 visitors (0 registered, 42 guests [including 5 identified bots]).
Forum time: 09:46 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5